ADC值鉴别子宫肉瘤与子宫肌瘤的效用:系统综述与Meta分析
本系统综述与Meta分析纳入21项研究,评估ADC值鉴别子宫肉瘤与子宫肌瘤的诊断性能,汇总敏感度89%、特异度86%、AUC 0.94;ADC作为多参数MRI组成部分时特异度95%高于单独评估的82%,敏感度相似;作者认为ADC值小于0.904×10⁻³ mm²/s或可作为子宫肉瘤的检查阳性阈值。
要点
- ADC值鉴别子宫肉瘤与肌瘤汇总敏感度89%、特异度86%、AUC 0.94。
- ADC作为多参数MRI组成部分时特异度95%,高于单独ADC评估的82%。
- 作者认为ADC值小于0.904×10⁻³ mm²/s或可作为子宫肉瘤检查阳性阈值。
核心结论
- 作为子宫肿块多参数MRI评估的一部分,肿块ADC值小于0.904×10⁻³ mm²/s或可作为子宫肉瘤的检查阳性阈值,与既往专家共识声明的发现一致。
- 机构方案可能影响本地选择的ADC值。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、Embase和Cochrane三个电子数据库,纳入使用MRI(包括ADC值)区分子宫肉瘤与肌瘤、以病理组织确认或影像随访为参考标准的研究,共21项研究符合纳入标准。
- 采用QUADAS-2进行质量评估,使用双变量和分层汇总ROC模型汇总敏感度和特异度,并用Meta回归评估异质性影响因素。
- 试验注册:前瞻性系统综述注册库CRD42024499383。
诊断标准与关键数值
- 汇总敏感度89%(95%CI 82-94%),汇总特异度86%(95%CI 78-92%),汇总ROC曲线下面积0.94(95%CI 0.92-0.96)。
- ADC作为多参数MRI特征之一评估时,特异度95%(95%CI 92-99%)高于单独ADC评估的82%(95%CI 75-89%),敏感度相似:94%(95%CI 89-99%)vs 88%(95%CI 82-93%)。
- ADC截断值范围为0.87至1.29×10⁻³ mm²/s,不同截断值与诊断性能无统计学差异(p=.37)。
- 肉瘤和肌瘤的汇总平均ADC值分别为0.904×10⁻³ mm²/s和1.287×10⁻³ mm²/s。
- ADC解读背景(单独评估vs作为多参数MRI组成部分)是唯一显著解释异质性的因素(p=.01)。
临床应用与阅片要点
- 作者认为,作为子宫肿块多参数MRI评估的一部分,肿块ADC值小于0.904×10⁻³ mm²/s或可作为子宫肉瘤的检查阳性阈值,与既往专家共识声明的发现一致。
- 机构方案可能影响本地选择的ADC值。
- 将ADC作为多参数MRI评估的一部分可改善子宫肉瘤的检测,可能影响微创治疗的候选者选择。
局限性
- ADC解读背景是唯一显著解释异质性的因素(p=.01)。
- 机构方案可能影响本地选择的ADC值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Uterine sarcomas are rare; however, they display imaging features that overlap those of leiomyomas. The potential for undetected uterine sarcomas is clinically relevant because minimally invasive treatment of leiomyomas may lead to cancer dissemination. ADC values have shown potential for differentiating benign from malignant uterine masses. OBJECTIVE. The purpose of this study was to perform a systematic review of the diagnostic performance of ADC values in differentiating uterine sarcomas from leiomyomas. EVIDENCE ACQUISITION. We searched three electronic databases (the MEDLINE, Embase, and Cochrane databases) for studies distinguishing uterine sarcomas from leiomyomas using MRI, including ADC values, with pathologic tissue confirmation or imaging follow-up used as the reference standard. Data extraction and QUADAS-2 quality assessment were performed. Sensitivity and specificity were pooled using hierarchical models, including bivariate and hierarchical summary ROC models. Metaregression was used to assess the impact of various factors on heterogeneity. EVIDENCE SYNTHESIS. Twenty-one studies met the study inclusion criteria. Pooled sensitivity and specificity were 89% (95% CI, 82-94%) and 86% (95% CI, 78-92%), respectively. The area under the summary ROC curve was 0.94 (95% CI, 0.92-0.96). The context of the ADC interpretation (i.e., used as a stand-alone assessment vs integrated as part of multiparametric MRI [mpMRI]) was the only factor found to account significantly for heterogeneity (p = .01). Higher specificity (95% [95% CI, 92-99%] vs 82% [95% CI, 75-89%]) and similar sensitivity (94% [95% CI, 89-99%] vs 88% [95% CI, 82-93%]) were observed when ADC was evaluated among mpMRI features rather than as a stand-alone ADC assessment. ADC cutoff values ranged from 0.87 to 1.29 × 10-3 mm2/s but were not associated with statistically different performance (p = .37). Pooled mean ADC values for sarcomas and leiomyomas were 0.904 × 10-3 mm2/s and 1.287 × 10-3 mm2/s, respectively. CONCLUSION. As part of mpMRI evaluation of uterine masses, a mass ADC value of less than 0.904 × 10-3 mm2/s may be a useful test-positive threshold for uterine sarcoma, consistent with the findings of a prior expert consensus statement. Institutional protocols may influence locally selected ADC values. CLINICAL IMPACT. Using ADC as part of mpMRI assessment improves detection of uterine sarcoma, which could influence candidate selection for minimally invasive treatments. TRIAL REGISTRATION. Prospective Register of Systematic Reviews CRD42024499383.
引用
- Woo S, Beier SR, Tong A, et al. Utility of ADC Values for Differentiating Uterine Sarcomas From Leiomyomas: Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2024. PMID: 38899844. doi:10.2214/AJR.24.31280
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。